Specify Company / Ticker to Get the Summary
Dividend History PRFX
Dividend Analytics PRFX
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Painreform Ltd
PRFXPainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel. Address: 65 Yigal Alon St., Tel Aviv, Israel, 6744316
Analytics
WallStreet Target Price
12.00 USDP/E Ratio
–Dividend Yield
–Financials PRFX
Results | 2019 | Dynamics |